Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SealFoam
- Development stage
- Unknown
- Lead developer
- Starch Medical
- Administration
- Topical
01
Overview
SealFoam is a starch-derived, polysaccharide-based hemostatic sponge manufactured by Starch Medical, Inc. It is a topical medical device designed to achieve rapid hemostasis during surgical procedures, including cardiac, orthopedic, and general surgery. The sponge works through a physical mechanism, absorbing the fluid component of blood to concentrate endogenous platelets and clotting factors at the site of injury, thereby accelerating the natural coagulation cascade. SealFoam is available in specialized formulations such as SealFoam Sternal and is designed to be fully absorbable by the body.
- Brand names
- SealFoamSealFoam Sternal
- Other names
- Starch-derived hemostatic spongePolysaccharide-based hemostat
Beyond the preview
Go deeper on SealFoam.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SealFoam.